Zobrazeno 1 - 10
of 376
pro vyhledávání: '"Satoshi, Kubo"'
Autor:
Satoshi Kubo, Yoshiya Tanaka
Publikováno v:
Immunological Medicine, Vol 47, Iss 2, Pp 52-57 (2024)
AbstractMixed connective tissue disease (MCTD) is an autoimmune disorder characterized by a combination of clinical features from systemic lupus erythematosus, systemic sclerosis, and inflammatory muscle disease, along with the presence of positive a
Externí odkaz:
https://doaj.org/article/e78ec4002d834c01aa8e0e539c1f1ccd
Autor:
Satoshi Kubo, Yoshiya Tanaka
Publikováno v:
European Medical Journal Rheumatology (2024)
Externí odkaz:
https://doaj.org/article/30bea58972bf458999f4d0ac868d010a
Autor:
Yoshiya Tanaka, Hiroaki Tanaka, Satoshi Kubo, Yuya Fujita, Shingo Nakayamada, Kaoru Yamagata, Ryuichiro Kanda, Aya Nawata, Koshiro Sonomoto, Shan Yu, Yurie Satoh-Kanda, Shunpei Kosaka
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objectives The tuning effects of JAK/TYK2 inhibitors on the imbalance between T follicular helper (Tfh) and T regulatory (Treg) cells, related to systemic lupus erythematosus (SLE) pathogenesis, were investigated using human peripheral blood samples.
Externí odkaz:
https://doaj.org/article/cb5f943baafe4816af2aa665e3cfa2a2
Autor:
Hiroaki Tanaka, Satoshi Kubo, Shingo Nakayamada, Yusuke Miyazaki, Ippei Miyagawa, Koshiro Sonomoto, Masashi Funada
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To investigate the early detection of pulmonary non-tuberculous mycobacterial (PNTM) disease by CT before the initiation of molecular-targeted therapeutic drugs in patients with rheumatoid arthritis (RA) and the efficacy and safety of combi
Externí odkaz:
https://doaj.org/article/9f24b13ac8bf4863b1a6b5a6a664896b
Autor:
Satoshi Kubo, Yusuke Miyazaki, Yasuyuki Todoroki, Atsushi Nagayasu, Ryuichiro Kanda, Takafumi Aritomi, Satsuki Matsunaga, Masanobu Ueno, Ippei Miyagawa, Koshiro Sonomoto, Kentaro Hanami, Shingo Nakayamada, Yoshiya Tanaka
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1705-1723 (2023)
Abstract Introduction The study aimed to optimize medical care for elderly patients with rheumatoid arthritis (RA) by examining the 3-year continuation rate of different molecular targeted therapies across age groups in Japan, which has a significant
Externí odkaz:
https://doaj.org/article/b785ecf42d384ab6bb228e8905f0c53f
Autor:
Keiichi Torimoto, Yosuke Okada, Shingo Nakayamada, Satoshi Kubo, Akira Kurozumi, Manabu Narisawa, Yoshiya Tanaka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Graves' disease (GD) is an organ-specific autoimmune disease, but there are a few studies that have evaluated how immunophenotypes are related to clinical symptoms and intractable pathology, or the effects of treatment on immunophenotypes. W
Externí odkaz:
https://doaj.org/article/dcdb7b94f4004b71b43120d23e904dd0
Autor:
Masanobu Ueno, Ippei Miyagawa, Yusuke Miyazaki, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Shingo Nakayamada, Yoshiya Tanaka
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-11 (2022)
Abstract Objectives We compared the treatment effectiveness between guselkumab and adalimumab in patients with pustulotic arthro-osteitis (PAO). In addition, we performed peripheral blood immunophenotyping to elucidate the immunological background an
Externí odkaz:
https://doaj.org/article/ff616076af7047cd88f4e52023605435
Autor:
Masanobu Ueno, Ippei Miyagawa, Takafumi Aritomi, Koichi Kimura, Shigeru Iwata, Kentaro Hanami, Syunsuke Fukuyo, Satoshi Kubo, Yusuke Miyazaki, Shingo Nakayamada, Yoshiya Tanaka
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-9 (2022)
Abstract Objectives To investigate the safety and effectiveness of mepolizumab (MPZ), an anti-interleukin-5 antibody, as remission induction therapy for severe eosinophilic granulomatosis with polyangiitis (EGPA). Methods The clinical courses of pati
Externí odkaz:
https://doaj.org/article/9290d9137b7144738f6c7cc216030254
Autor:
Yuko Kaneko, Hideto Kameda, Yoshiya Tanaka, Satoshi Kubo, Koichi Amano, Shingo Nakayamada, Yusuke Miyazaki, Kiyoshi Matsui, Yoshino Inoue, Kunihiro Yamaoka, Takehisa Ogura
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective To investigate sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis.Methods Patients who had an inadequate response to methotrexate (MTX) with or without biological disease-modifying antirhe
Externí odkaz:
https://doaj.org/article/4267bc8365004aff9bd271fa347e299f
Autor:
Ippei Miyagawa, Shingo Nakayamada, Masanobu Ueno, Yusuke Miyazaki, Shigeru Iwata, Satoshi Kubo, Koshiro Sonomoto, Junpei Anan, Naoaki Ohkubo, Yoshino Inoue, Yoshiya Tanaka
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background We explored whether serum cytokines could be used as biomarkers for optimal use of tumor necrosis factor inhibitors (TNF-i) and interleukin (IL)-17 inhibitors (IL-17-i) in patients with psoriatic arthritis (PsA). Methods In cohort
Externí odkaz:
https://doaj.org/article/a3c9e3bf0f3c4952839348a8578adc7b